Oxaliplatin-induced hepatoportal sclerosis, portal hypertension, and variceal bleeding successfully treated with transjugular intrahepatic portosystemic shunt

MeSH terms

• Antibodies, Monoclonal, Humanized / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Bevacizumab
• Colorectal Neoplasms / drug therapy*
• Colorectal Neoplasms / surgery
• Esophageal and Gastric Varices / chemically induced
• Esophageal and Gastric Varices / surgery*
• Female
• Fluorouracil / administration & dosage
• Gastrointestinal Hemorrhage / chemically induced
• Gastrointestinal Hemorrhage / surgery*
• Humans
• Hypertension, Portal / chemically induced
• Hypertension, Portal / surgery
• Leucovorin / administration & dosage
• Middle Aged
• Organoplatinum Compounds / administration & dosage
• Organoplatinum Compounds / adverse effects*
• Oxaliplatin
• Portal System / pathology*
• Portasystemic Shunt, Transjugular Intrahepatic*
• Sclerosis / chemically induced
• Sclerosis / complications
• Sclerosis / surgery